The Centers for Medicare & Medicaid Services (CMS) is moving to significantly reduce payment rates for drugs acquired through the 340B Drug Pricing Program, citing evidence that some patients paid …
Tag:
STAT+
-
-
STAT’s AI Prognosis Newsletter Addresses Artificial Intelligence in Healthcare The STAT AI Prognosis newsletter, a subscriber-exclusive publication from STAT, focuses on artificial intelligence (AI) applications in healthcare and medicine. According …
-
Anthropic Expands into Drug Development, Leveraging AI for Scientific Breakthroughs San Francisco-based AI company Anthropic has announced its entry into pharmaceutical research, signaling a significant shift in the application of …
-
French biotechnology company Abivax has released updated safety data for its experimental ulcerative colitis drug, obefazimod, following concerns regarding cancer cases observed during clinical trials. The company reported that a …
-
Senator Bill Cassidy (R-La.), ranking member of the Senate Health, Education, Labor, and Pensions (HELP) Committee, has introduced legislative proposals aimed at reforming the 340B Drug Pricing Program. The program, …
-
Eli Lilly Invests $40 Million in Hair Loss Startup Absci, Expanding Aesthetic Drug Portfolio Eli Lilly & Co. has invested $40 million in Absci, a biotechnology startup focused on developing …
-
U.S. FDA Decides Against Further Action on Whoop’s Blood Pressure Feature The U.S. Food and Drug Administration (FDA) has decided not to pursue further enforcement action against wearable company Whoop …
-
Pfizer Lung Cancer Trial Fails to Meet Primary Endpoint as FDA Moves to Accelerate Drug Development Pfizer’s experimental lung cancer drug, sigvotatug vedotin, failed to demonstrate a statistically significant improvement …
-
Sanofi Names Paulo Fontoura as New Global Head of R&D Sanofi, the French pharmaceutical giant, has appointed Paulo Fontoura as its new global head of research and development, effective September …
-
Protego Biopharma Appoints Jae Kim as Chief Medical Officer Protego Biopharma has named Jae Kim as its new chief medical officer (CMO), according to a company announcement released June 19, …